4 Stocks Pushing The Health Services Industry Higher
TheStreet Ratings group would like to highlight 4 stocks pushing the health services industry higher today, Nov. 15, 2012.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our modelAll three major indices are trading down today with the Dow Jones Industrial Average (^DJI) trading down 46 points (-0.4%) at 12,524 as of Thursday, Nov. 15, 2012, 12:05 PM ET. The NYSE advances/declines ratio sits at 797 issues advancing vs. 2,184 declining with 91 unchanged.The Health Services industry currently sits down 0.7% versus the S&P 500, which is down 0.4%. Top gainers within the industry include Cigna (CI), up 1.8%, and Express Scripts (ESRX), up 0.7%. On the negative front, top decliners within the industry include Mindray Medical International (MR), down 2.2%, Cooper Companies (COO), down 1.3%, HCA Holdings (HCA), down 1.0% and Thermo Fisher Scientific (TMO), down 0.8%.TheStreet Ratings group would like to highlight 4 stocks pushing the industry higher today:4. Health Net (HNT) is one of the companies pushing the Health Services industry higher today. As of noon trading, Health Net is up $0.73 (3.1%) to $24.58 on average volume Thus far, 391,752 shares of Health Net exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $23.80-$24.63 after having opened the day at $23.80 as compared to the previous trading day's close of $23.85. Health Net, Inc., through its subsidiaries, provides managed health care services. Health Net has a market cap of $2.0 billion and is part of the health care sector. The company has a P/E ratio of 30.6, above the S&P 500 P/E ratio of 17.7. Shares are down 18.4% year to date as of the close of trading on Wednesday. Currently there are no analysts that rate Health Net a buy, 3 analysts rate it a sell, and 11 rate it a hold.TheStreet Ratings rates Health Net as a hold. Among the primary strengths of the company is its solid financial position based on a variety of debt and liquidity measures that we have evaluated. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and disappointing return on equity. Get the full Health Net Ratings Report now.Latest Headlines about BAX
-
Cramer's Top Stock Picks: BSX BAX FB
06:00AM 05/18/13
-
Cramer's 'Mad Money' Recap: Next Week's Game Plan
08:19PM 05/17/13
-
Dow Closes Over 15,000 as Global Central Banks Take Stimulus Actions
05:03PM 05/07/13
-
An Investor's Choice: J&J or Baxter International?
06:00AM 04/19/13
-
5 Names Seeing Bullish Options Flow
12:16PM 04/18/13
-
5 Health Care Stocks Triggering 'Buys' This Week
07:00AM 02/20/13
-
Baxter to Buy Gambro for $2.8B: Hot Trends
10:00AM 12/04/12
Latest from TheStreet Wire
-
General Electric Stock To Go Ex-dividend Tomorrow (GE)
01:49PM 06/19/13
-
WellPoint Stock Hits New 52-Week High (WLP)
01:33PM 06/19/13
-
5 Stocks Pushing The Insurance Industry Downward
01:03PM 06/19/13
-
4 Stocks Dragging The Specialty Retail Industry Downward
01:03PM 06/19/13
-
SNE, CL And KMB, Pushing Consumer Goods Sector Downward
01:03PM 06/19/13
-
5 Stocks Pulling The Industrial Industry Downward
01:03PM 06/19/13
-
4 Computer Software & Services Stocks Dragging The Industry Down
01:03PM 06/19/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
